Your browser doesn't support javascript.
loading
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Nachman, Sharon; Ahmed, Amina; Amanullah, Farhana; Becerra, Mercedes C; Botgros, Radu; Brigden, Grania; Browning, Renee; Gardiner, Elizabeth; Hafner, Richard; Hesseling, Anneke; How, Cleotilde; Jean-Philippe, Patrick; Lessem, Erica; Makhene, Mamodikoe; Mbelle, Nontombi; Marais, Ben; McIlleron, Helen; McNeeley, David F; Mendel, Carl; Murray, Stephen; Navarro, Eileen; Anyalechi, E Gloria; Porcalla, Ariel R; Powell, Clydette; Powell, Mair; Rigaud, Mona; Rouzier, Vanessa; Samson, Pearl; Schaaf, H Simon; Shah, Seema; Starke, Jeff; Swaminathan, Soumya; Wobudeya, Eric; Worrell, Carol.
Afiliación
  • Nachman S; SUNY at Stony Brook, Stony Brook, NY, USA. Electronic address: sharon.nachman@stonybrook.edu.
  • Ahmed A; Levine Children's Hospital at Carolinas Medical Center, Charlotte, NC, USA.
  • Amanullah F; Indus Hospital, Pakistan.
  • Becerra MC; Harvard Medical School, Boston, MA, USA.
  • Botgros R; European Medicines Agency, London, UK.
  • Brigden G; Médecins Sans Frontières, Access Campaign, Geneva, Switzerland.
  • Browning R; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS, Bethesda, MD, USA.
  • Gardiner E; TB Alliance, New York, NY, USA.
  • Hafner R; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS, Bethesda, MD, USA.
  • Hesseling A; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • How C; Department of Pharmacology and Toxicology, University of the Philippines, Manila, Philippines.
  • Jean-Philippe P; Henry M Jackson Foundation-Division of AIDS, Contractor to National Institutes of Health, National Institute of Allergy and Infectious Diseases, Department of Health and Human Services, Bethesda, MD, USA.
  • Lessem E; Treatment Action Group, New York, NY, USA.
  • Makhene M; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS, Bethesda, MD, USA.
  • Mbelle N; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
  • Marais B; Marie Bashir Institute for Infectious Diseases and Biosecurity and the Sydney Emerging Infectious Diseases and Biosecurity Institute and The Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, Australia.
  • McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.
  • McNeeley DF; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • Mendel C; TB Alliance, New York, NY, USA.
  • Murray S; TB Alliance, New York, NY, USA.
  • Navarro E; Division of Anti-Infective Products; Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Anyalechi EG; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, International Research and Programs Branch, Atlanta, GA, USA.
  • Porcalla AR; Division of Anti-Infective Products; Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Powell C; US Agency for International Development, Washington, DC, USA.
  • Powell M; European Medicines Agency, London, UK.
  • Rigaud M; New York University School of Medicine, NY, USA.
  • Rouzier V; GHESKIO, Port-au-Prince, Haiti.
  • Samson P; Statistical and Data Analysis Center, Center for Biostatistics in AIDS Research and Frontier Science, Harvard School of Public Health, Boston, MA, USA.
  • Schaaf HS; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Shah S; Department of Bioethics, NIH Clinical Center, Bethesda, MD, USA.
  • Starke J; Baylor College of Medicine, Houston, TX, USA.
  • Swaminathan S; National Institute for Research in Tuberculosis, Chennai, India.
  • Wobudeya E; Makerere University Johns Hopkins Research Collaboration, and Mulago National Referral Hospital, Kampala, Uganda.
  • Worrell C; Eunice Kennedy Schriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
Lancet Infect Dis ; 15(6): 711-20, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25957923
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Ensayos Clínicos como Asunto / Antituberculosos Tipo de estudio: Guideline Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Ensayos Clínicos como Asunto / Antituberculosos Tipo de estudio: Guideline Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos